Graybug Vision, Inc. (NASDAQ:GRAY – Get Free Report) shares shot up 7.4% during mid-day trading on Thursday . The company traded as high as $2.39 and last traded at $2.31. 37,450 shares were traded during trading, an increase of 1,630% from the average session volume of 2,165 shares. The stock had previously closed at $2.15.
Graybug Vision Stock Up 7.4 %
The stock has a market cap of $3.63 million, a price-to-earnings ratio of -1.34 and a beta of 1.20. The business has a 50-day moving average of $2.80 and a 200-day moving average of $3.53.
About Graybug Vision
Graybug Vision, Inc, a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema.
Recommended Stories
- Five stocks we like better than Graybug Vision
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- 5 Best Gold ETFs for March to Curb Recession Fears
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
- The Risks of Owning Bonds
- Why Smart Investors Are Watching These 3 Undervalued Stocks
Receive News & Ratings for Graybug Vision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Graybug Vision and related companies with MarketBeat.com's FREE daily email newsletter.
